Healthcare Leadership, Policy & Digital Health News IndiaHealthcare Leadership, Policy & Digital Health News IndiaHealthcare Leadership, Policy & Digital Health News India
  • Home
  • News
  • Articles
  • Exclusive
  • HB Originals
  • Gallery
  • Advertisement
Healthcare Leadership, Policy & Digital Health News IndiaHealthcare Leadership, Policy & Digital Health News India
  • Medical Science
Search
  • Home
  • Categories
    • Medical Science
    • Health Awareness
  • Bookmarks
  • More Foxiz
    • Sitemap
Follow US
  • Advertise
© 2025 Health Hub Media Pvt Ltd. All Rights Reserved.
Healthcare Leadership, Policy & Digital Health News India > Blog > Frontline Focus > Hyderabad Doctors Sound Alarm! Avoid OTC Cough Syrups in Young Kids

Hyderabad Doctors Sound Alarm! Avoid OTC Cough Syrups in Young Kids

Published: October 16, 2025
SHARE

Pediatricians in Hyderabad are urging parents to stop using over-the-counter (OTC) cough syrups for small children following the nationwide toxic syrup scandal.

Glimpse:

Amid mounting child fatalities linked to contaminated cough syrups, Hyderabad’s pediatric community has issued a safety alert. They warn that self-medication with cough and cold syrups in children especially under age four can be dangerous. The state’s drug authorities are already banning suspect brands and implementing stricter testing protocols.

Following reports of multiple child deaths due to tainted cough syrups, pediatricians in Hyderabad have warned against the use of over-the-counter cough and cold medicines especially in young children. They emphasize that many such syrups contain combination formulations not recommended for children under four years.

Doctors advise that treatment should focus on addressing underlying causes (allergy, mucus, cold symptoms) rather than blindly using suppressants. Repeated or incorrect dosing could provoke severe side effects like bronchospasm or even kidney damage in sensitive cases.

The Telangana Drugs Control Administration has already banned two suspect syrups ReLife and Respifresh after lab alerts about diethylene glycol (DEG) contamination. Clinicians recommend switching to safer alternatives, using non-drug remedies (steam inhalation, hydration, nasal drops), and ensuring any medicine is prescribed by a qualified physician.

“Self-medication may seem easy, but in children it can cross invisible danger thresholds.”

By

HB Team

Related News

Unihealth Expands African Footprint with Entebbe Deal, Boosts Capacity to 150 Beds

April 24, 2026

Graviti Pharma Expands South India Footprint with Strategic Karnataka Entry

April 24, 2026

Delhi Cantt Hospital Goes HighTech with Robotic Surgery Boost

April 24, 2026

Medtronic Brings Smart Brain Tech to India: A Game Changer for Parkinson’s Care

April 24, 2026

Premji Invest Backs Newera Hospitals to Expand Advanced Care Beyond Metro Cities

April 23, 2026

Venkaiah Naidu Unveils Atal MedTech Museum to Showcase India’s Healthcare Innovation Journey

April 23, 2026

Boehringer Ingelheim Launches £150M AI Hub in London to Accelerate Drug Discovery

April 23, 2026

Kotak Mahindra Bank Backs Advanced Diagnostics Upgrade at Mumbai’s Somaiya Hospital

April 23, 2026

Odisha Approves ₹3,877 Cr Investments to Accelerate Pharma and MedTech Growth

April 23, 2026

India Emerges as Global Leader in AI-Driven Healthcare Adoption

April 22, 2026

Aster CMI Introduces Karnataka’s First Dedicated Pediatric Liver ICU for Critical Care

April 22, 2026

India Launches First AI Driven Rural Medical Hub to Bridge Village Healthcare Gap

April 21, 2026

AI Meets Radiology at Scale: DeepTek and deepc Unite for Smarter Clinical Workflows

April 21, 2026

Apollo Hospitals Expands Tech-Driven Care to Sri City

April 21, 2026

Baptist Health Expands Rural Footprint with Magnolia Hospital Acquisition

April 19, 2026

New Leadership on the Horizon: CDC Eyes Stability with Erica Schwartz Nomination

April 21, 2026

eClinicalWorks CEO: Scaling AI Innovation in Healthcare Must Never Compromise Reliability or Safety

April 21, 2026

NHA Launches Digital Academy to Power India’s Next-Gen Healthcare Workforce

April 20, 2026

OpenAI Unveils GPT-Rosalind to Accelerate Drug Discovery and Life Sciences Research

April 20, 2026

Telemedicine in India: Key Rules Every Doctor Must Follow in the Digital Care Era

April 20, 2026
Jaslok Hospital Launches AI-Based Clinical Study for Early Prediction of Parkinson’s Disease
Biocon Raises ₹4,150 Crore Through QIP to Acquire Full Ownership of Biocon Biologics
Avista Therapeutics Expands AI-Driven Gene Therapy Platform to Accelerate Genetic Medicine Delivery
AFMS and IISc Forge Strategic Partnership: AI, Robotics, and Wearables to Revolutionize Combat Medicine for Indian Armed Forces
Significo Secures Series B, Hits $100M Valuation as Health AI Play
Your browser does not support the audio element.
Your browser does not support the audio element.

Contact us

Privacy Policy

Terms & Conditions

HealthBuzz is a leading platform for healthcare news in India, covering hospital leadership updates, health policy developments, digital health innovations, and emerging healthcare startups. Stay informed with the latest insights shaping India’s healthcare ecosystem.

Facebook Twitter Youtube Whatsapp

Quick Links

  • Home
  • Articles
  • HB Originals
  • News
  • Videos
  • Gallery

Company

  • About us
  • Contact Us
  • Privacy Policy
  • Terms & Conditions
  • Content Complaince

Install our Mobile App for Best Experience

Healthcare Leadership, Policy & Digital Health News IndiaHealthcare Leadership, Policy & Digital Health News India
Follow US
Health Hub Media Pvt. Ltd. © 2026 All Rights Reserved
Welcome Back!

Sign in to your account

Username or Email Address
Password

Lost your password?